| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2013 ( Subtotal = $0 ) |
| 2013 | 2012 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R01AI094424 | PA-50/PA-41 ANTITOXIN ANTIBODY THERAPY FOR C. DIFFICILE INFECTION | 000 | 2 | NIH | 1/29/2013 | $0 |
| 2013 | 2010 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | RC4AI092728 | NOVEL, NON-ANTIBIOTIC THERAPY FOR CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE | 000 | 1 | NIH | 3/22/2013 | $0 |
|
 | Issue Date FY: 2012 ( Subtotal = -$4,508,738 ) |
| 2012 | 2012 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R01AI094424 | PA-50/PA-41 ANTITOXIN ANTIBODY THERAPY FOR C. DIFFICILE INFECTION | 000 | 2 | NIH | 4/11/2012 | $1,128,535 |
| 2012 | 2011 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | P01AI082362 | Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers | 001 | 3 | NIH | 12/7/2011 | -$2,610,975 |
| 2012 | 2011 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U01AI095085 | LONG-ACTING, SELF-ADMINISTERED HIV THERAPY WITH TH CCR5 ANTIBODY PRO 140 | 000 | 1 | NIH | 8/3/2012 | -$3,026,298 |
|
 | Issue Date FY: 2011 ( Subtotal = $6,903,422 ) |
| 2011 | 2011 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U01AI095085 | LONG-ACTING, SELF-ADMINISTERED HIV THERAPY WITH TH CCR5 ANTIBODY PRO 140 | 000 | 1 | NIH | 5/17/2011 | $3,026,298 |
| 2011 | 2011 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | P01AI082362 | Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers | 000 | 3 | NIH | 6/8/2011 | $2,753,455 |
| 2011 | 2011 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R01AI094424 | PA-50/PA-41 ANTITOXIN ANTIBODY THERAPY FOR C. DIFFICILE INFECTION | 000 | 1 | NIH | 4/29/2011 | $1,123,669 |
|
 | Issue Date FY: 2010 ( Subtotal = $7,339,639 ) |
| 2010 | 2010 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | P01AI082362 | Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers | 001 | 2 | NIH | 7/23/2010 | $0 |
| 2010 | 2010 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | P01AI082362 | Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers | 000 | 2 | NIH | 5/19/2010 | $2,781,188 |
| 2010 | 2010 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U19AI066329 | HIV-1 THERAPY WITH CCR5 MAB PRO 140-OVERVIEW | 002 | 4 | NIH | 9/27/2010 | $414,799 |
| 2010 | 2010 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | RC4AI092728 | NOVEL, NON-ANTIBIOTIC THERAPY FOR CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE | 000 | 1 | NIH | 9/29/2010 | $4,143,652 |
| 2010 | 2009 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U19AI066329 | HIV-1 THERAPY WITH CCR5 MAB PRO 140-OVERVIEW | 001 | 4 | NIH | 7/26/2010 | $0 |
| 2010 | 2009 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | P01AI082362 | Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers | 002 | 1 | NIH | 7/23/2010 | $0 |
| 2010 | 2008 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43AI073223 | NOVEL SMALL-MOLECULE INHIBITORS OF HIV-1 VIF | 000 | 2 | NIH | 6/4/2010 | $0 |
| 2010 | 2008 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U19AI066329 | HIV-1 THERAPY WITH CCR5 MAB PRO 140-OVERVIEW | 000 | 4 | NIH | 7/26/2010 | $0 |
|
 | Issue Date FY: 2009 ( Subtotal = $3,441,252 ) |
| 2009 | 2009 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | P01AI082362 | Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers | 000 | 1 | NIH | 6/9/2009 | $2,284,835 |
| 2009 | 2009 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | P01AI082362 | Structure and Immunogenicity of Cleaved, Stabilized HIV-1 Envelope Trimers | 001 | 1 | NIH | 9/23/2009 | $575,700 |
| 2009 | 2009 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U19AI066329 | HIV-1 THERAPY WITH CCR5 MAB PRO 140-OVERVIEW | 002 | 4 | NIH | 8/10/2009 | -$414,799 |
| 2009 | 2009 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U19AI066329 | HIV-1 THERAPY WITH CCR5 MAB PRO 140-OVERVIEW | 001 | 4 | NIH | 7/14/2009 | $995,516 |
| 2009 | 2008 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44CA095928 | PSMA-VRP VACCINE FOR PROSTATE CANCER | 000 | 4 | NIH | 12/4/2008 | $0 |
| 2009 | 2008 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U19AI066329 | HIV-1 THERAPY WITH CCR5 MAB PRO 140-OVERVIEW | 000 | 4 | NIH | 8/19/2009 | $0 |
| 2009 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44CA096075 | HUMAN PSMA MAB RADIOIMMUNOTHERAPY FOR PROSTATE CANCER | 000 | 6 | NIH | 8/18/2009 | $0 |
|
 | Issue Date FY: 2008 ( Subtotal = $4,617,012 ) |
| 2008 | 2008 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U19AI066329 | HIV-1 THERAPY WITH CCR5 MAB PRO 140-OVERVIEW | 000 | 4 | NIH | 2/25/2008 | $2,987,862 |
| 2008 | 2008 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43AI073223 | NOVEL SMALL-MOLECULE INHIBITORS OF HIV-1 VIF | 000 | 2 | NIH | 2/29/2008 | $300,000 |
| 2008 | 2008 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43AI072780 | BROADLY NEUTRALIZING MABS AGAINST HEPATITIS C VIRUS | 000 | 2 | NIH | 3/12/2008 | $287,309 |
| 2008 | 2008 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44CA107653 | PSMA ANTIBODY-DRUG CONJUGATE FOR PROSTATE CANCER THERAPY | 000 | 4 | NIH | 8/25/2008 | $466,948 |
| 2008 | 2008 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44CA095928 | PSMA-VRP VACCINE FOR PROSTATE CANCER | 000 | 4 | NIH | 8/13/2008 | $574,893 |
|
 | Issue Date FY: 2007 ( Subtotal = $7,590,892 ) |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43CA121640 | DEVELOPEMENT OF AN ALPHAVIRUS VACCINE FOR MELANOMA | 000 | 2 | NIH | 9/25/2007 | $298,527 |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44CA107653 | PSMA ANTIBODY-DRUG CONJUGATE FOR PROSTATE CANCER THERAPY | 000 | 3 | NIH | 9/14/2007 | $473,537 |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44CA096075 | HUMAN PSMA MAB RADIOIMMUNOTHERAPY FOR PROSTATE CANCER | 000 | 6 | NIH | 9/13/2007 | $971,397 |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44CA095928 | PSMA-VRP VACCINE FOR PROSTATE CANCER | 000 | 3 | NIH | 9/28/2007 | $428,780 |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44CA091746 | DEVELOPMENT OF PSMA -BASED RECOMBINANT PROTEIN VACCINES | 000 | 5 | NIH | 8/23/2007 | $895,094 |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44AI051134 | DEVELOPMENT OF HEPATITIS C VIRUS INHIBITORS | 000 | 5 | NIH | 8/21/2007 | $1,030,553 |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | U19AI066329 | HIV-1 THERAPY WITH CCR5 MAB PRO 140-OVERVIEW | 000 | 3 | NIH | 4/4/2007 | $2,544,127 |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43AI072780 | BROADLY NEUTRALIZING MABS AGAINST HEPATITIS C VIRUS | 000 | 1 | NIH | 4/20/2007 | $351,433 |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43AI073223 | NOVEL SMALL-MOLECULE INHIBITORS OF HIV-1 VIF | 000 | 1 | NIH | 4/12/2007 | $291,281 |
| 2007 | 2007 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43AI069675 | BROADLY INHIBITORY MABS TARGETING HEPATITIS C VIRUS RECEPTORS | 000 | 2 | NIH | 8/28/2007 | $306,163 |
|
 | Issue Date FY: 2006 ( Subtotal = $6,550,879 ) (Continued on the next page) |
| 2006 | 2006 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43CA121640 | DEVELOPEMENT OF AN ALPHAVIRUS VACCINE FOR MELANOMA | 000 | 1 | NIH | 6/30/2006 | $316,469 |
| 2006 | 2006 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R43AI069675 | BROADLY INHIBITORY MABS TARGETING HEPATITIS C VIRUS RECEPTORS | 000 | 1 | NIH | 8/30/2006 | $313,107 |
| 2006 | 2006 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44CA096075 | HUMAN PSMA MAB RADIOIMMUNOTHERAPY FOR PROSTATE CANCER | 000 | 5 | NIH | 8/16/2006 | $1,000,000 |
| 2006 | 2006 | PROGENICS PHARMACEUTICALS, INC | OLD SAW MILL RIVER ROAD | TARRYTOWN | NY | 10591 | WESTCHESTER | USA | R44AI051134 | DEVELOPMENT OF HEPATITIS C VIRUS INHIBITORS | 000 | 4 | NIH | 8/4/2006 | $1,001,572 |
|